New York, New York, United States The main office of represented VC is situated in the New York. The company was established in North America in United States.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Ediscovery, Biotechnology. Among the various public portfolio startups of the fund, we may underline Oligomerix Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2012.
The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Wheatley Partners, Wheatley MedTech Partners. In the next rounds fund is usually obtained by National Institutes of Health.
Funds with similar focus
| Fund Name | Location |
| 32 Equity | New York, New York, United States |
| DHV partners | - |
| Dingxin Ruitong | Beijing, China, Fengtai |
| Employee Stock Option Fund (ESO Fund) | California, San Mateo, United States |
| FountainVest Partners | China, Hong Kong, Hong Kong Island |
| GSTC Health Innovations | - |
| Jincheng Rongchuang | China, Jiangsu, Suzhou |
| Kingsley Ventures | England, London, United Kingdom |
| Magic Fund | California, Los Angeles, United States |
| marchFirst | Chicago, Illinois, United States |
| Martha Stewart Living Omnimedia | New York, New York, United States |
| McDATA Corporation | Broomfield, Colorado, United States |
| NTT Finance | Japan, Tokyo |
| One97 | India, Noida, Uttar Pradesh |
| Redwood Venture Partners | California, Los Altos, United States |
| Shenshahai Chuangye Touzi | Chengguan District, China, Lhasa |
| Tate Family Trust | Alabama, Huntsville, United States |
| WRF Capital | Seattle, United States, Washington |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Oligomerix | $2M | 23 Apr 2012 | New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Oligomerix | $2M | 23 Apr 2012 | New York, United States |
